Evidence map›Paper›PMID 41236077›Full record

ReviewJournal of the International AIDS Society2025

The time is now to use the tools we have to end AIDS in children.

Lara Vojnov, Roger L Shapiro, Lloyd B Mulenga, Adeodata R Kikitiinwa, Alexandra C Vrazo, Patricia Fassinou Ekouévi, Nelly Pato Dindi, Appolinaire Tiam, Deborah Persaud, Lynne Mofenson

Abstract readReview
In one paragraph

Review in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Progress and Challenges in Elimination of Vertical HIV Transmission.Journal of the International AIDS Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lara VojnovGlobal Health Impact Group, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-0488-1012
Roger L ShapiroDepartment of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Lloyd B MulengaZambian Ministry of Health, Lusaka, Zambia.
Adeodata R KikitiinwaBaylor College of Medicine Children's Foundation, Kampala, Uganda.
Alexandra C VrazoUnited States Agency for International Development, Washington, DC, USA.ORCID https://orcid.org/0000-0002-7216-9302
Patricia Fassinou EkouéviElizabeth Glaser Pediatric AIDS Foundation, Abidjan, Cote d'Ivoire.
Nelly Pato DindiNational AIDS & STI Control Programme (NASCOP), Ministry of Health, Nairobi, Kenya.
Appolinaire TiamMilken Institute School of Public Health, Department of Epidemiology and Biostatistics, George Washington University, Washington, DC, USA.
Deborah PersaudDivision of Infectious Diseases, Department of Pediatrics, Johns Hopkins University of School of Medicine, Baltimore, Maryland, USA.
Lynne MofensonElizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProgress in reducing and eliminating vertical transmission of HIV in children has stagnated over recent years. Unfortunately, recent decisions in the global donor space are likely to lead to considerably lower funding available for HIV and other disease programmes in high-burden low- and middle-income settings. Understanding and implementing the most effective strategies to prevent, diagnose, treat and monitor HIV acquisition in children are critical to maximize available resources and provide the best care for children. DISCUSSION: A set of tools to support the elimination of vertical transmission and end AIDS in children exists across the cascade of care for pregnant mothers and their children, including those for prevention, diagnosis, treatment, monitoring and service delivery. Each tool comes with its own challenges in implementation and scale-up; however, the effectiveness of many has been well-studied and documented. Ensuring all women living with HIV have consistent and secure access to optimized antiretroviral therapy will prevent the largest number of leaks in the cascade that can lead to vertical transmission events. Implementing effective infant diagnosis strategies, including same-day point-of-care testing and birth testing where feasible, will lead to earlier and faster identification of children living with HIV. Subsequently, rapid linkage to optimized treatment will save and improve the lives of children living with HIV. Finally, implementing accompanying monitoring modalities and country-specific service delivery approaches will improve implementation and the effectiveness of these tools as well as retention and commitment in care programmes by children as they become adolescents and adults.

conclusionsEnding AIDS in children is possible. We have the tools to do so. However, now is the time for national, regional and global stakeholders to come together to prioritize children and ensure appropriate funding, implementation and equitable access are in place. Testing infants quickly and accurately for HIV is the first step to ensuring their lifelong health and wellbeing. As national and global public health structures shift, programmes need to act quickly-gains in paediatric HIV cannot be lost but must be accelerated. Doing so will require political will, financing, infrastructure, community-led initiatives, and commitment by and access to all to achieve those goals.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsInfectious Disease Transmission, VerticalChildChild, PreschoolFemaleHumansInfantInfant, NewbornPregnancyPregnancy Complications, Infectiousbirth testinginfant diagnosisinnovationslast milepaediatric HIVpoint‐of‐caretreatment

Identifiers

PMID41236077
PMCPMC12616873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.